Translate Proteins From Biomarker Candidates to Verified Biomarkers

Targeted mass spectrometry gives researchers the power to move beyond the constraints of traditional immunoassays when validating protein biomarkers. Yet cross-reactivity, limited multiplexing, and inconsistent reproducibility continue to slow the path from candidate to verified biomarker. Parallel reaction monitoring (PRM) offers a robust, high-throughput alternative that delivers the accuracy and sensitivity this stage demands. In this on-demand webinar, Dr. Stefani Thomas shows how PRM is being used to identify and prioritize predictive biomarkers of drug resistance in ovarian cancer. Watch this webinar to learn: - How to apply mass spectrometry during biomarker verification - The advantages of PRM for targeted MS applications - Key guidelines on peptide and protein quantification using targeted MS